Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
1-Alkyl- and Azeto[1,2-a][1,5]benzodiazepine Derivatives in the Reaction of o-Phenylenediamine with 3-(Dimethylamino)propiophenonesInsuasty, Braulio ; Abonia, Rodrigo ; Quiroga, Jairo ; Salcedo, Angela ; Kolshorn, Heinz ; Meier, HerbertEuropean journal of organic chemistry, 2000-05, Vol.2000 (10), p.1973-1976 [Periódico revisado por pares]Weinheim: WILEY-VCH Verlag GmbHTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
1-Substituted 2-heteroadamantanesGagneux, André R. ; Meier, RenéTetrahedron letters, 1969-01, Vol.10 (17), p.1365-1368 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapyGrimm, P D ; Blasko, J C ; Sylvester, J E ; Meier, R M ; Cavanagh, WInternational journal of radiation oncology, biology, physics, 2001-09, Vol.51 (1), p.31-40 [Periódico revisado por pares]United StatesTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
10 Year Prostate Stereotactic Body Radiotherapy Outcomes: Relapse-free Survival, PSA Kinetics And Toxicity From A Pooled Analysis Of Two Multi-Institutional TrialsFuller, D.B. ; Chen, R.C. ; Crabtree, T. ; Kaplan, I.D. ; Meier, R.International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e857-e858 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
1079P Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naïve and pretreated patients with advanced melanoma within the German noninterventional study NICOGutzmer, R. ; Eigentler, T. ; Mohr, P. ; Weichenthal, M. ; Dücker, P. ; Gebhardt, C. ; Göppner, D. ; Grimmelmann, I. ; Haferkamp, S. ; Kähler, K.C. ; Meier, F. ; Pföhler, C. ; Sickmann, T. ; Sindrilaru, A. ; Terheyden, P. ; Ugurel, S. ; Ulrich, J. ; Utikal, J. ; Weishaupt, C. ; Schadendorf, D.Annals of oncology, 2021-09, Vol.32, p.S894-S895 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
1084P PLATForM: Descriptive analysis from a randomised, phase II study of novel spartalizumab combinations in previously treated unresectable/metastatic melanomaRobert, C. ; Schadendorf, D. ; Long, G.V. ; Ascierto, P. ; Intagliata, S. ; Meier, F. ; van der Veldt, A.A.M. ; Ribas, A. ; Weber, J.S. ; Stenson, L. ; Solovieff, N. ; Louveau, A-L. ; Boran, A.D. ; Grob, J.J. ; Dummer, R.Annals of oncology, 2021-09, Vol.32, p.S898-S898 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
1087MO A single arm phase II, multicenter trial to evaluate the clinical activity and safety of avelumab plus cetuximab in unresectable stage III or IV cutaneous squamous cell carcinoma: First results from the AliCe studyBecker, J.C. ; Schilling, B. ; Leiter-Stoppke, U. ; Zimmer, L. ; Hassel, J.C. ; von Wasielewski, I. ; Ziemer, M. ; Fluck, M. ; Meier, F. ; Spillner, A. ; Gesierich, A. ; Eigentler, T. ; Livingstone, E. ; Albers, M. ; Angela, Y. ; Gutzmer, R.Annals of oncology, 2023-10, Vol.34, p.S654-S655 [Periódico revisado por pares]Elsevier LtdSem texto completo |
8 |
Material Type: Artigo
|
![]() |
[11] Promotion of cyst(e)ine uptakeMeier, Thomas ; Issels, Rolf D.Methods in Enzymology, 1995, Vol.252, p.103-112 [Periódico revisado por pares]United States: Elsevier Science & TechnologyTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
1104P Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO+IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICOGutzmer, R. ; Eigentler, T. ; Mohr, P. ; Weichenthal, M. ; Dücker, P. ; Gebhardt, C. ; Göppner, D. ; Haferkamp, S. ; Kähler, K. ; Meier, F. ; Pföhler, C. ; Satzger, I. ; Sickmann, T. ; Sindrilaru, A. ; Terheyden, P. ; Ugurel, S. ; Ulrich, J. ; Utikal, J. ; Weishaupt, C. ; Schadendorf, D.Annals of oncology, 2020-09, Vol.31, p.S746-S747 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
1107P BRAF mutation status does not impact outcomes with tebentafusp in advanced cutaneous melanomaShoushtari, A.N. ; Middleton, M.R. ; Hamid, O. ; Meier, F. ; Bauer, T. ; Salama, A.K.S. ; Kirkwood, J.M. ; Ascierto, P.A. ; Lorigan, P. ; Mauch, C. ; Orloff, M. ; Edukulla, R. ; Goodall, H. ; Hassel, J.C. ; Evans, T.R.J.Annals of oncology, 2023-10, Vol.34, p.S667-S668 [Periódico revisado por pares]Elsevier LtdSem texto completo |